Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 91351-91400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05002452
Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC
N/ARecruiting
150 participants
Started: Dec 20, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06881329
Epigenome-wide DNA Methylation Profiling in Aneurysmal Subarachnoid Hemorrhage and Delayed Ischemic Neurologic Deficit
N/AActive, not recruiting
61 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT05071963
INSPIRE Pipeline™ Shield Post Approval Study
N/AActive, not recruiting
246 participants
Started: Dec 20, 2021 · Completed: Apr 30, 2028
1 condition1 sponsor16 locations
NCT05218395
Association Between Persistent Organic Pollutants and Type 2 Diabetes /Thyroid Cancer
N/ARecruiting
900 participants
Started: Dec 20, 2021 · Completed: Dec 30, 2025
3 conditions2 sponsors1 location
NCT04921527
Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer
PHASE3Recruiting
454 participants
Started: Dec 20, 2021 · Completed: Jul 31, 2025
4 conditions1 sponsor1 location
NCT05210803
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
N/AEnrolling by invitation
115 participants
Started: Dec 20, 2021 · Completed: Mar 31, 2028
6 conditions1 sponsor16 locations
NCT04770753
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Non-Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-NTDT)
PHASE3Active, not recruiting
194 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2028
2 conditions1 sponsor68 locations
NCT04819100
A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)
PHASE3Active, not recruiting
152 participants
Started: Dec 20, 2021 · Completed: May 31, 2028
1 condition2 sponsors211 locations
NCT06187337
Interceptive Maxillary Expansion to Relief Anterior Crowding in the Mixed Dentition
NARecruiting
60 participants
Started: Dec 20, 2021 · Completed: Jan 31, 2028
3 conditions1 sponsor4 locations
NCT05712824
V-Lap System For Wirelessly Measuring And Monitoring Left Atrial Pressure (LAP) In Patients With Advance CHF
NARecruiting
10 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT05474417
The Effects of the CF Carrier State on the Kidneys and Pancreas
N/ARecruiting
1,250 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05157386
Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety
N/AActive, not recruiting
50 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2025
14 conditions2 sponsors1 location
NCT05174351
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
NARecruiting
30 participants
Started: Dec 20, 2021 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT04842006
Systemic Neoadjuvant and Adjuvant Control by Precision Medicine in Rectal Cancer
NARecruiting
93 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2031
1 condition1 sponsor2 locations
NCT06191172
The Effect of Person-Centered Care Applied to Patients With Dementia on Nutritional Status
NAActive, not recruiting
55 participants
Started: Dec 20, 2021 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT06121804
Immunosuppressants to Postoperative Infection and Death
N/ARecruiting
20,000 participants
Started: Dec 20, 2021 · Completed: Dec 20, 2024
3 conditions1 sponsor1 location
NCT05162573
EBRT + Lu-PSMA for N1M0 Prostate Cancer
PHASE1Recruiting
24 participants
Started: Dec 20, 2021 · Completed: Jul 1, 2025
1 condition3 sponsors2 locations
NCT04510636
Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
PHASE2Recruiting
37 participants
Started: Dec 20, 2021 · Completed: Jun 1, 2026
3 conditions1 sponsor1 location
NCT05474430
Estimating Risk of Respiratory Infections Attributable to CFTR Heterozygosity
N/ARecruiting
160 participants
Started: Dec 20, 2021 · Completed: Jul 31, 2025
2 conditions3 sponsors1 location
NCT04974216
Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
PHASE2Active, not recruiting
71 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor15 locations
NCT05264753
PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects
N/ARecruiting
255 participants
Started: Dec 20, 2021 · Completed: Nov 25, 2026
1 condition1 sponsor8 locations
NCT04989894
Quality of Recovery After Childbirth
N/ARecruiting
122 participants
Started: Dec 20, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05060627
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients, Refractory to Lenalidomide
PHASE1/PHASE2Recruiting
60 participants
Started: Dec 20, 2021 · Completed: May 30, 2028
1 condition2 sponsors15 locations
NCT05156203
Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Dec 19, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor3 locations
NCT06764576
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
N/ARecruiting
13,000 participants
Started: Dec 19, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05207254
Research on the Application of Artificial Intelligence Ultrasonic Recognition Technology in Difficult Airway Assessment
N/ARecruiting
4,000 participants
Started: Dec 18, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05535621
68Ga-HER2 Affibody PET/CT Imaging for HER2-Positive Cancer Patients
N/ARecruiting
100 participants
Started: Dec 18, 2021 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05095701
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
PHASE4Enrolling by invitation
703 participants
Started: Dec 18, 2021 · Completed: Oct 1, 2025
1 condition1 sponsor2 locations
NCT05252715
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 Months
PHASE3Active, not recruiting
1,200 participants
Started: Dec 18, 2021 · Completed: Sep 18, 2024
1 condition1 sponsor2 locations
NCT06773533
Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral Metabolism
N/ARecruiting
3,000 participants
Started: Dec 18, 2021 · Completed: Dec 31, 2039
1 condition1 sponsor1 location
NCT05153889
Low Risk Non ST Elevation Myocardial Infarction With or Without Intensive Care Unit Admission
NARecruiting
320 participants
Started: Dec 18, 2021 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT06575140
Associative Peripheral Stimulation for Reduction of Motor Impairment During Acute Period of Stroke Recovery
NARecruiting
20 participants
Started: Dec 18, 2021 · Completed: Dec 31, 2024
9 conditions1 sponsor3 locations
NCT04701437
Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants
NARecruiting
80 participants
Started: Dec 17, 2021 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT04463498
Sleep in Psychiatric Care (SIP): A Transdiagnostic Group-based Sleep-school as Treatment for Comorbid Insomnia
NARecruiting
60 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT05007132
Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
PHASE2Recruiting
153 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2032
1 condition1 sponsor1 location
NCT05192382
A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)
PHASE3Active, not recruiting
111 participants
Started: Dec 17, 2021 · Completed: Jan 31, 2028
1 condition1 sponsor57 locations
NCT05067283
A Study of MK-1084 in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
PHASE1Recruiting
830 participants
Started: Dec 17, 2021 · Completed: Feb 25, 2030
1 condition1 sponsor71 locations
NCT04782713
Smart Prostate Specific Antigen (PSA) Screening Study
NAActive, not recruiting
49 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05164341
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL
PHASE3Active, not recruiting
69 participants
Started: Dec 17, 2021 · Completed: Oct 31, 2026
1 condition1 sponsor31 locations
NCT06812806
Correlation Between the Change in the Antero-posterior Diameter of the Pelvic Side and the Incidence of Post-partum Urinary Incontinence
N/ARecruiting
240 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05041842
Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
PHASE2Active, not recruiting
53 participants
Started: Dec 17, 2021 · Completed: Apr 30, 2026
1 condition3 sponsors15 locations
NCT05207046
The ACCESSIT Study
N/ARecruiting
30 participants
Started: Dec 17, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05096923
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
N/ARecruiting
500 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2031
4 conditions2 sponsors1 location
NCT05423977
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
PHASE1Enrolling by invitation
36 participants
Started: Dec 17, 2021 · Completed: Jul 7, 2026
1 condition1 sponsor1 location
NCT04500847
Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD
PHASE1Recruiting
35 participants
Started: Dec 17, 2021 · Completed: Mar 31, 2026
3 conditions5 sponsors2 locations
NCT05305950
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
N/AActive, not recruiting
60 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05525637
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
PHASE3Recruiting
1,041 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor88 locations
NCT05038735
Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.
PHASE3Active, not recruiting
212 participants
Started: Dec 17, 2021 · Completed: Oct 15, 2026
1 condition1 sponsor68 locations
NCT05767385
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
PHASE2/PHASE3Recruiting
150 participants
Started: Dec 17, 2021 · Completed: Dec 31, 2025
4 conditions3 sponsors5 locations
NCT04991467
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
NARecruiting
360 participants
Started: Dec 17, 2021 · Completed: May 31, 2026
2 conditions3 sponsors1 location